1. Kodavanti UP. Respiratory toxicity biomarkers. In: Kodavanti U, Gupta R. Biomarkers in Toxicology. San Diego: Academic Press. 2014; pp: 217-39.

2. Vogel J, Hui S, Hua CH, Dusenbery K, Rassiah P, Kalapurakal J, et al. Pulmonary Toxicity After Total Body Irradiation - Critical Review of the Literature and Recommendations for Toxicity Reporting. Front Oncol. 2021 Aug;11:708906. https://doi.org/10.3389/fonc.2021.708906. [DOI] [PubMed]

3. Laprise-Lachance M, Lemieux P, Grégoire JP. Risk of pulmonary toxicity of bleomycin and filgrastim. J Oncol Pharm Pract. 2019 Oct;25(7):1638-44. https://doi.org/10.1177/1078155218804293. [DOI] [PubMed]

4. Sadowska AM, Specenier P, Germonpre P, Peeters M. Antineoplastic therapy-induced pulmonary toxicity. Expert Rev Anticancer Ther. 2013 Aug;13(8):997-1006. https://doi.org/10.1586/14737140.2013.817684. [DOI] [PubMed]

5. Fischer J, Ganellin CR. Analogue-based drug discovery. Chemistry International--Newsmagazine for IUPAC. 2010;32(4):5-12. [Link]

6. Chokesuwattanaskul R, Shah N, Chokesuwattanaskul S, Liu Z, Thakur R. Low-dose Amiodarone Is Safe: A Systematic Review and Meta-analysis. J Innov Card Rhythm Manag. 2020 Apr;11(4):4054-61. https://doi.org/10.19102/icrm.2020.110403. [DOI] [PubMed]

7. Singh BN. Amiodarone as paradigm for developing new drugs for atrial fibrillation. J Cardiovasc Pharmacol. 2008 Oct;52(4):300-5. https://doi.org/10.1097/fjc.0b013e31818914b6. [DOI] [PubMed]

8. Vrobel TR, Miller PE, Mostow ND, Rakita L. A general overview of amiodarone toxicity: its prevention, detection, and management. Prog Cardiovasc Dis. 1989 May-Jun;31(6):393-426. https://doi.org/10.1016/0033-0620(89)90016-9. [DOI] [PubMed]

9. Wolkove N, Baltzan M. Amiodarone pulmonary toxicity. Can Respir J. 2009 Mar-Apr;16(2):43-48. https://doi.org/10.1155/2009/282540. [DOI] [PubMed]

10. Feduska ET, Thoma BN, Torjman MC, Goldhammer JE. Acute Amiodarone Pulmonary Toxicity. J Cardiothorac Vasc Anesth. 2021 May;35(5):1485-94. https://doi.org/10.1053/j.jvca.2020.10.060. [DOI] [PubMed]

11. Mitrofan CE, Cretu A, Mitrofan C, Bar C, Ghiciuc CM. Amiodarone induced lung disease. Arch Clin Cases. 2022 Sep;9(3):126-32. https://doi.org/10.22551/2022.36.0903.10217. [DOI] [PubMed]

12. Shokrzadeh M, Rahmati Kukandeh M, Kargar Darabi N, Modanloo M, Fallah M, Mohammadpour A. [Cellular Effects of Naringin in Prevention of Genotoxicity Caused by Mifepristone on Human Blood Lymphocytes]. J Mazandaran Univ Med Sci. 2018; 28(161):115-20. [Article in Persian] [Link]

13. Liu Q, Lanari MC, Schaefer DM. A review of dietary vitamin E supplementation for improvement of beef quality. J Anim Sci. 1995 Oct;73(10):3131-40. https://doi.org/10.2527/1995.73103131x. [DOI] [PubMed]

14. Naghdi Badi H, Makkizadeh M. [Review of common thyme]. J. Med. Plants 2003;2(7):1-12. [Article in Persian] [Link]

15. Bina R, Heidari R, Mohammadzadeh M, ilkhanipour M. [Effects aqueous extract of thyme Thymus vulgaris L on blood biochemical parameters and liver tissue in rats under immobilization stress]. Journal of Animal Research (Iranian Journal of Biology). 2019; 32(1): 1-10. [Article in Persian] [Link]

16. Ghassemi-Barghi N, Varshosaz J, Etebari M, Jafarian Dehkordi A. Role of recombinant human erythropoietin loading chitosan-tripolyphosphate nanoparticles in busulfan-induced genotoxicity: Analysis of DNA fragmentation via comet assay in cultured HepG2 cells. Toxicol In Vitro. 2016 Oct;36:46-52. https://doi.org/10.1016/j.tiv.2016.07.001. [DOI] [PubMed]

17. Sundararajan R, Salameh T, Camarillo IG, Prabu RR, Natarajan A, Sankaranarayanan K. Irreversible electroporation: a drug-free cancer treatment. Sundararajan R. In: Irreversible electroporation: a drug-free cancer treatment. Electroporation-Based Therapies for Cancer. Cambridge: Woodhead Publishing. 2014; pp: 219-43. [Link]

18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec;65(1-2):55-63. https://doi.org/10.1016/0022-1759(83)90303-4. [DOI] [PubMed]

19. Sylvester PW. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Methods Mol Biol. 2011;716:157-68. https://doi.org/10.1007/978-1-61779-012-6_9. [DOI] [PubMed]

20. van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol Biol. 2011;731:237-45. https://doi.org/10.1007/978-1-61779-080-5_20. [DOI] [PubMed]

21. Manosroi J, Dhumtanom P, Manosroi A. Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett. 2006 Apr;235(1):114-20. https://doi.org/10.1016/j.canlet.2005.04.021. [DOI] [PubMed]

22. Young IS, McEneny J. Lipoprotein oxidation and atherosclerosis. Biochem Soc Trans. 2001 May;29(Pt 2):358-62. https://doi.org/10.1042/0300-5127:0290358. [DOI] [PubMed]

23. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991 Aug;288(2):481-87. https://doi.org/10.1016/0003-9861(91)90224-7. [DOI] [PubMed]

24. Jenkins RR. Free radical chemistry. Relationship to exercise. Sports Med. 1988 Mar;5(3):156-70. https://doi.org/10.2165/00007256-198805030-00003. [DOI] [PubMed]

25. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta. 1998 Aug;1366(1-2):53-67. https://doi.org/10.1016/s0005-2728(98)00120-0. [DOI] [PubMed]

26. Meng XX, Wang RL, Gao S, Xie H, Tan JT, Qian YB. Effect of ulinastatin on paraquat-induced-oxidative stress in human type II alveolar epithelial cells. World J Emerg Med. 2013;4(2):133-37. https://doi.org/10.5847/wjem.j.issn.1920-8642.2013.02.009. [DOI] [PubMed]

27. Budin CE, Cocuz IG, Sabău AH, Niculescu R, Ianosi IR, Ioan V, et al. Pulmonary Fibrosis Related to Amiodarone-Is It a Standard Pathophysiological Pattern? A Case-Based Literature Review. Diagnostics (Basel). 2022 Dec;12(12):3217. https://doi.org/10.3390/diagnostics12123217. [DOI] [PubMed]

28. Nacca N, Bhamidipati CM, Yuhico LS, Pinnamaneni S, Szombathy T. Severe amiodarone induced pulmonary toxicity. J Thorac Dis. 2012 Dec;4(6):667-70. https://doi.org/10.3978/j.issn.2072-1439.2012.06.08. [DOI] [PubMed]

29. Card JW, Racz WJ, Brien JF, Massey TE. Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-beta1 gene expression but not prevention of mitochondrial dysfunction. J Pharmacol Exp Ther. 2003 Jan;304(1):277-83. https://doi.org/10.1124/jpet.102.043208. [DOI] [PubMed]

30. Arise RO, Olapade EO, Olufemi O, Yekeen AA. Taurine and vitamin E protect against pulmonary toxicity in rats exposed to cigarette smoke. Scientific African. 2021 Sep; 13: e00923. https://doi.org/10.1016/j.sciaf.2021.e00923. [Link] [DOI]

31. Pandur E, Micalizzi G, Mondello L, Horváth A, Sipos K, Horváth G. Antioxidant and Anti-Inflammatory Effects of Thyme (Thymus vulgaris L.) Essential Oils Prepared at Different Plant Phenophases on Pseudomonas aeruginosa LPS-Activated THP-1 Macrophages. Antioxidants (Basel). 2022 Jul;11(7):1330. https://doi.org/10.3390/antiox11071330. [DOI] [PubMed]

32. Hussein RM, Arafa EA, Raheem SA, Mohamed WR. Thymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-β and PI3K/Akt signaling in mice. Life Sci. 2023 Feb;314:121256. https://doi.org/10.1016/j.lfs.2022.121256. [DOI] [PubMed]

33. Soliman MM, Aldhahrani A, Metwally MMM. Hepatoprotective effect of Thymus vulgaris extract on sodium nitrite-induced changes in oxidative stress, antioxidant and inflammatory marker expression. Sci Rep. 2021 Mar;11(1):5747. https://doi.org/10.1038/s41598-021-85264-9. [DOI] [PubMed]

34. Kubatka P, Uramova S, Kello M, Kajo K, Samec M, Jasek K, et al. Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma in Vivo and in Vitro. Int J Mol Sci. 2019 Apr;20(7):1749. https://doi.org/10.3390/ijms20071749. [DOI] [PubMed]

35. Zeng Q, Che Y, Zhang Y, Chen M, Guo Q, Zhang W. Thymol Isolated from Thymus vulgaris L. Inhibits Colorectal Cancer Cell Growth and Metastasis by Suppressing the Wnt/β-Catenin Pathway. Drug Des Devel Ther. 2020 Jul;14:2535-47. https://doi.org/10.2147/dddt.s254218. [DOI] [PubMed]

36. You HS, Yoon JH, Cho SB, Choi YD, Kim YH, Choi W, et al. Amiodarone-Induced Multi-Systemic Toxicity Involving the Liver, Lungs, Thyroid, and Eyes: A Case Report. Front Cardiovasc Med. 2022 Feb;9:839441. https://doi.org/10.3389/fcvm.2022.839441. [DOI] [PubMed]

37. Fatima N, Mandava K, Khatoon F, Badar J, Begum SF, Narasimhan C, et al. CLI nical Profile and Side Effects of chronic use of oral Amiodarone in cardiology outpatients department (CLIPSE-A Study)- A prospective observational study. Ann Med Surg (Lond). 2022 Jul;80:104167. https://doi.org/10.1016/j.amsu.2022.104167. [DOI] [PubMed]

38. Șorodoc V, Indrei L, Dobroghii C, Asaftei A, Ceasovschih A, Constantin M, et al. Amiodarone Therapy: Updated Practical Insights. J Clin Med. 2024 Oct;13(20):6094. https://doi.org/10.3390/jcm13206094. [DOI] [PubMed]